Monoclonal B-cell lymphocytosis is characterized by mutations in CLL putative driver genes and clonal heterogeneity many years before disease progression
Ojha, J, Secreto, C, Rabe, K, Ayres-Silva, J, Tschumper, R, Dyke, D V, Slager, S, Fonseca, R, Shanafelt, T, Kay, N, Braggio, E
Published in Leukemia (01.12.2014)
Published in Leukemia (01.12.2014)
Get full text
Journal Article
Genomic characterization of high-count MBL cases indicates that early detection of driver mutations and subclonal expansion are predictors of adverse clinical outcome
Barrio, S, Shanafelt, T D, Ojha, J, Chaffee, K G, Secreto, C, Kortüm, K M, Pathangey, S, Van-Dyke, D L, Slager, S L, Fonseca, R, Kay, N E, Braggio, E
Published in Leukemia (01.01.2017)
Published in Leukemia (01.01.2017)
Get full text
Journal Article
Early Results of Pentostatin, Cytoxan, Rituximab (PCR) Followed by CAMPATH-H (CA) for the Treatment of Relapse/Refractory Chronic Lymphocytic Leukemia (CLL) in ECOG Protocol E2903
Kempin, Sanford, Kay, N.E., Sun, Z., Secreto, C., Tschumper, R.C., Jelinek, D.F., Smoley, S., Van Dyke, D., Saltzman, J., Rosen, S., Tallman, M.S.
Published in Blood (16.11.2007)
Published in Blood (16.11.2007)
Get full text
Journal Article
A Phase 1 Trial of Daily Oral Green Tea Extract in Asymptomatic, Rai Stage 0–II Patients with Chronic Lymphocytic Leukemia
Shanafelt, T.D., Kaufmann, S.H., Call, T.G., Zent, Clive S., Wu, W., Bowen, D.A., Secreto, C., Ghosh, A.K., Kabat, B., Yang, C.S., Jelinek, D.F., Erlichman, C., Kay, Neil E.
Published in Blood (16.11.2007)
Published in Blood (16.11.2007)
Get full text
Journal Article